REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 90 filers reported holding REATA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $492 | +10.1% | 29,700 | -20.6% | 0.07% | +47.8% |
Q1 2023 | $447 | +81.0% | 37,400 | +274.0% | 0.05% | +130.0% |
Q4 2022 | $247 | -99.8% | 10,000 | -17.0% | 0.02% | +122.2% |
Q3 2022 | $129,000 | -16.2% | 12,054 | +63.2% | 0.01% | -10.0% |
Q2 2022 | $154,000 | -65.1% | 7,386 | -90.1% | 0.01% | -56.5% |
Q1 2022 | $441,000 | +70.9% | 74,402 | +66.0% | 0.02% | +130.0% |
Q4 2021 | $258,000 | +87.0% | 44,832 | +296.7% | 0.01% | +66.7% |
Q3 2021 | $138,000 | +165.4% | 11,300 | +583.2% | 0.01% | +200.0% |
Q2 2021 | $52,000 | -46.9% | 1,654 | -37.8% | 0.00% | -60.0% |
Q1 2021 | $98,000 | +1533.3% | 2,660 | +195.6% | 0.01% | – |
Q4 2020 | $6,000 | -98.3% | 900 | -87.7% | 0.00% | -100.0% |
Q3 2020 | $361,000 | +1404.2% | 7,300 | +4462.5% | 0.02% | +1000.0% |
Q2 2020 | $24,000 | -88.5% | 160 | -98.5% | 0.00% | -81.8% |
Q1 2020 | $208,000 | -73.4% | 11,000 | -15.8% | 0.01% | -77.1% |
Q4 2019 | $783,000 | +252.7% | 13,061 | -5.4% | 0.05% | +140.0% |
Q3 2019 | $222,000 | -53.2% | 13,800 | +72.0% | 0.02% | -54.5% |
Q2 2019 | $474,000 | +8.5% | 8,025 | -38.9% | 0.04% | -2.2% |
Q1 2019 | $437,000 | +893.2% | 13,125 | +1540.6% | 0.04% | +1025.0% |
Q4 2018 | $44,000 | -47.6% | 800 | -94.2% | 0.00% | -20.0% |
Q3 2018 | $84,000 | +394.1% | 13,800 | +1433.3% | 0.01% | +400.0% |
Q2 2018 | $17,000 | +70.0% | 900 | +80.0% | 0.00% | 0.0% |
Q1 2018 | $10,000 | -9.1% | 500 | +25.0% | 0.00% | – |
Q4 2017 | $11,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |